Protocol - Self-reported Tobacco Product Price Paid - E-Cigarettes
Protocol Name from Source:This section will be completed when reviewed by an Expert Review Panel.
This protocol includes questions from the Wave 1 Adult Population Assessment of Tobacco and Health (PATH) Survey instrument. These specific questions are used to measure the price paid for e-cigarettes.
1. Do you own an e-cigarette?
[ ] 1 Yes
[ ] 2 No [END QUESTIONNAIRE]
[ ] -8 DON’T KNOW [END QUESTIONNAIRE]
[ ] -7 REFUSED [END QUESTIONNAIRE]
ASK: Respondents who have used an e-cigarette
2. About how much did you pay for your e-cigarette? Do not include the cost of additional cartridges or accessories unless they were included in a starter kit.
[ ] 1 Less than $10
[ ] 2 $10 to $20
3 [ ] $21 to $100
4 [ ] More than $100
[ ] -8 DON’T KNOW
[ ] -7 REFUSED
ASK: Respondents who own an e-cigarette (Q1 = 1)
Personnel and Training Required
|Average time of greater than 15 minutes in an unaffected individual||No|
|Specialized requirements for biospecimen collection||No|
Mode of Administration
To answer these questions, investigators will need to determine whether or not the respondent has ever used an e-cigarette. To do so, the Working Group is recommending that investigators add the Use of Tobacco Products Toolkit measure.
June 24, 2015
DefinitionInstrument used to assess the price paid for cigarettes, cigars, e-cigarettes, and smokeless tobacco by consumers.
The purpose of this measure is to assess the price paid for cigarettes, cigars, e-cigarettes, and smokeless tobacco and how price affects consumer behavior.
The Population Assessment of Tobacco and Health (PATH) Study is a nationally representative, in-person longitudinal cohort study of nonusers and users of tobacco products and those at risk for tobacco use across the United States. Respondents 12 years old and up are asked questions on tobacco use, attitudes, and health, and biospecimens (buccal cell, urine, and blood) are collected from adults. The PATH Study was implemented to provide an evidence base for assessing and monitoring the Food and Drug Administration’s regulatory actions in meeting its mandate under the Family Smoking Prevention and Tobacco Control Act. Regulatory domains include product standards, new and modified risk products, health warnings, and health education campaigns.
|Common Data Elements (CDE)||Electronic Cigarette Cost Assessment Text||4884684||CDE Browser|
Process and Review
This section will be completed when reviewed by an Expert Review Panel.
National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA), Population Assessment of Tobacco and Health (PATH) Study, PATH Wave 1 Adult Extended Interview 7.5, 2013, Items AE9004, AE1090.
National Institutes of Health, U.S. Food and Drug Administration. (2013). Population Assessment of Tobacco and Health (PATH) Study: Final Adult Baseline (Wave 1) Questionnaire. Bethesda, MD: National Institutes of Health.
|Variable Name||Variable ID||Variable Description||Version||dbGaP Mapping|
|PX740803_TobaccoPrice_Ecigarette_Own||PX740803010000||Do you own an e-cigarette?||4||N/A|
|PX740803_TobaccoPrice_Ecigarette_HowMuchPaid||PX740803020000||About how much did you pay for your e-cigarette? Do not include the cost of additional cartridges or accessories unless they were included in a starter kit.||4||N/A|